A Multi-Center Phase I Study of Intravenous Deforolimus (AP23573, MK-8669) Administered QDX5 Every Other Week in Pediatric Patients With Advanced Solid Tumors
This study is currently recruiting participants.
Study NCT00704054
Information provided by Ariad Pharmaceuticals
First Received: June 23, 2008
Last Updated: September 14, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
